Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

NCT00143884 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma, Low-Grade
Lymphoma, Non-Hodgkin's
Multiple Myeloma
Myelodysplastic Syndromes

Interventions

PROCEDURE: Reduced intensity conditioning
PROCEDURE: Prophylactic donor leukocyte infusions

Sponsor

University of Michigan Rogel Cancer Center